A colonoscopy is known to detect cancer on the left side of the colon but some had believed the test had a blind spot as to the right side of the colon. This study shows that the test is also effective in detecting cancer on the right side of the colon.
A new study finds that more than half of cancers arising after negative colonoscopies or after colon polyp removal were the result of missed lesions. The missed cancers can be the result of errors by the physician performing the colonoscopy, and may be medical malpractice. Contact Berger & Lagnese LLC in Pittsburgh for free consultation.
A new study found that recurrence of colon cancer can be prevented by giving certain patients a one week course of radiation therapy before surgical excision of the cancer tumor. The recurrence rate dropped by 50% in the study.
British researchers have linked popular osteoporosis drugs with increased incidence of colon, stomach and esophageal cancer. These drugs are known as bisphosphonates and are sold under numerous labels including Fosomax, Boniva, Reclast and Actonel.
New studies show that people with colon or rectal cancer live longer if they take aspirin on a regular basis. Patients with non-metastatic colorectal cancer may talk to their treating doctors about whether they are appropriate candidates for regular aspirin therapy.
Although prior studies have found a link between eating meat and increased incidence of colon cancer, this study explores the reasons why the two may be linked, and analyzes particular eating habits that are more risky.
Colon cancer is more prevalent in African-Americans, and new research shows this difference is due to genes that are susceptible to targeted drug treatment.
Cancer patients may be under-using their pain medicines for fear of side effects. Patients should discuss pain medication issues to gain understanding that using pain medicine to better control pain is beneficial and will lead to a better quality of life.
Thirty-two thousand deaths a year could be avoided if doctors screened every adult over age 50 for colon cancer. Forty percent of eligible patients in the United States are not screened for colon cancer as they should be.
Survival rate for colon cancer is linked with early diagnosis. Delayed diagnosis of colon cancer can led to unnecessary injury, and worsened prognosis including death. Blood tests for general inflammation can be linked to colon cancer and indicate heightened scrutiny for colon cancer diagnosis.
A new drug combination may kill polyps that lead to colon cancer. For free information about colon cancer, contact the colon cancer attorneys of Pittsburgh, Pennsylvania.
If your colon cancer was missed, misdiagnosed or not properly treated, you have come to the right place. Our attorneys specialize in colon cancer cases.
According to a recent study that was published in Cancer Epidemiology Biomarkers and Prevention, colorectal cancer rates are on the rise in the United States for people who are younger than 50.
The researchers reviewed data on 11,000 men and 9,800 women younger than 50. The data was obtained from 13 registeries that tracked the information between 1992 and 2005.
The researchers found that colorectal cancer rates increased 1.5% a year among men younger than 50 and 1.6% a year among women younger than 50. The researchers also found that incident rate increases for colorectal cancer had edged up in every age category below 50, but the largest increase occurred in the youngest age group (those between 20 and 29 years old).
Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. The American Cancer Society estimates that about 106,000 new cases of colon cancer, which includes about 15,000 people younger than 50, and 41,000 new cases of rectal cancer will be diagnosed this year.
A new study, performed at the University of Wisconsin School of Medicine and Public Health, establishes CT colonography as an effective primary screening test for colon cancer. There are several tests for diagnosing colon cancer.
The study included 479 patients with 739 CTC detected lesions.The results of the study showed that 677 of the739 lesions or 91.6%detected on CTC were also found during optical colonoscopy or surgery.
This study will be presented at the 2009 American Roentgen Ray Society (ARRS) Annual Meeting in Boston, Massachusetts. If you believe your colon cancer was missed or not diagnosed in time, you should contact the colon cancer attorneys of Pennsylvania. We specialize in medical malpractice cases involving failure to diagnose and treat colon cancer. Call us for a free evaluation.
People with advanced colon cancerwere modestly helped by the drug Erbitux (cetuximab), as long as they didn't have a particular gene mutation, a new study reports.Colorectal cancer is the third most common cancer worldwide.
The New England Journal of Medicinepublished the results of the study, which involved more than 1,100 people who had metastatic colorectal cancer that could not be surgically removed. Half were given a standard chemotherapy regimen, known as FOLFIRI, while the others were given a combination of Erbitux along with the standard regimen.
The study found that in those who had a normal form of the gene, Erbitux, which is administered intravenously, kept colorectal cancers from spreading 15% longer than did the FOLFIRI drugs alone.
Cetuximab was approved by the U.S. Food and Drug Administration in 2006 for use in squamous cell carcinoma of the head and neck. Since then, it's been increasingly used by doctors to treat colorectal cancer that has spread or recurred after other chemotherapy.
Clinical trials are ongoing to test Erbitux in people whose cancer has not yet metastasized.
Medicare has issued a proposed decision on whether it will cover/pay for CT colonoscopy, also called virtual colonoscopy or CT colonography, for use as a screening test for colon cancer. Medicare has proposed that it will not pay for it. It is asking for comments on its proposed decision. Medicare concluded that this test was not good enough at finding the smaller polyps that can lead to colon cancer.
CT colonography is performed as follows. First, the bowel is prepared similar to the preparation used for optical colonoscopy, and stool and fluid tagged with oral contrast. Then, a CT scan is performed in both supine and prone positions while the patient is fully conscious and produces images of the colon and rectum to assess the presence or absence of structural lesions such as polyps and colon cancer.
Originally, CT colonography produced colon images as a series of individual cross sectional images. With improved computer processing, these images can be combined into a fly-through presentation; this has led to CT colonography mimicking an optical colonoscopy.
Colon Cancer is curable. But it must be found and diagnosed early. There are several very good tests for diagnosing colon cancer, including colonoscopy and PET scans.
At the recent Gastrointestinal Cancers Symposium Meeting, researchers reported that patients who received panitumumab (Vectibix) plus FOLFOX or FOLFIRI actually had a faster progression and spread of metastatic colon cancer and were more likely to experience severe toxicities.
Those randomized to panitumumab plus oxaliplatin and bevacizumab (Avastin) had a mean progression-free survival of 9.5 months compared with 11 months in the oxaliplatin/bevacizumab arm.
Panitumumab, a fully human monoclonal antibody that targets EGFr, is approved for monotherapy for chemotherapy-refractory metastatic colon cancer.
A new study shows that computer-aided detection (CAD) significantly increases the ability of doctors to detect colon cancer when using multi-row detector CT (MDCT) colonography (CTC) to screen for colon cancer.
If you believe your colon cancer was missed or not diagnosed in time, you should contact the lawyers at Berger & Lagnese. Berger & Lagnese specializes in medical malpractice cases involving the failure to diagnose and treat colon cancer. Call us for a free evaluation of your case.
For a medical malpractice attorney in Pittsburgh, PA, I recommend Joshua Berger. I had a heart surgery that injured me. Attorney Berger got me a great settlement, prepared me well, and his law firm was kind and caring.
Attorney Paul Lagnese "He Understood"
The lawyers at Berger & Lagnese treated me with dignity and respect.
Attorney Josh Berger Recommended For Death of Man After Carotid Artery Surgery
Attorney David Paul reccomended for his outstanding job!
Attorney Paul Lagnese Recommended for Medical Malpractice Cases in Pittsburgh, Pennsylvania